People in prisons and other closed settings
The estimated global HIV prevalence in prisoners is 3%. In some settings, the HIV prevalence in prison is 15 times higher than in the general adult population. Recommended HIV prevention and treatment services are usually unavailable in prison settings: only about 5% of countries have needle/syringe programmes in prisons and only 1 in 3 provide prison based opioid substitution therapy. Condoms are available to prisoners in only 28 countries, although they are accessible through programmes in community settings worldwide.
WHO, working with UNODC and other partners, supports the implementation of comprehensive HIV services for people who live in prisons or other closed settings, including harm reduction services for those who use drugs.
Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key populations
Serving the needs of key populations: case examples of innovation and good practice in HIV prevention, diagnosis, treatment and care
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
17 million people with access to antiretroviral therapy